Munich, Germany

Ralf Mehrwald

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pari Pharma Gmbh. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralf Mehrwald. Retrieved from https://idiyas.com/inventor/ralf-mehrwald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ralf Mehrwald: Innovator in Pharmaceutical Compositions

Introduction

Ralf Mehrwald is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the delivery of therapeutic agents.

Latest Patents

Ralf Mehrwald holds two patents related to pharmaceutical compositions comprising cyclosporin. His inventions focus on liquid pharmaceutical compositions that include a therapeutically effective dose of cyclosporin, an aqueous carrier liquid, and solubilizing substances such as phospholipids and non-ionic surfactants. These compositions are designed for various applications, including oral, parenteral, nasal, mucosal, topical, and particularly pulmonary delivery in the form of an aerosol.

Career Highlights

Ralf Mehrwald is currently associated with Pari Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the formulation of cyclosporin, which is crucial for various medical treatments.

Collaborations

Ralf has collaborated with notable colleagues, including Manfred Keller and Aslihan Akkar, to further enhance the research and development of pharmaceutical compositions.

Conclusion

Ralf Mehrwald's contributions to pharmaceutical innovations, particularly in the area of cyclosporin compositions, highlight his role as a key inventor in the industry. His work continues to impact the field positively, paving the way for improved therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…